NewcelX Ltd.

About NewcelX Ltd.

NewcelX is an innovative biopharmaceutical company focused on transforming the future of type 1 diabetes and medicine through next-generation cell therapies. Utilizing platform technologies for regenerative cell therapies and novel active pharmaceutical ingredients (API), the company aims to treat type 1 diabetes, ALS, MS, and other CNS disorders. Founded in 2025 through the merger of Kadimastem Ltd. and NLS Pharmaceutics Ltd., NewcelX is dedicated to delivering functional cures and durable, accessible treatments for significant unmet medical needs.

Products & Services

IsletRx:A stem cell-derived islet therapy designed to restore insulin production in individuals with insulin-dependent diabetes, specifically targeting Type 1 Diabetes.

AstroRx(r):A validated asset focused on treating amyotrophic lateral sclerosis (ALS) through regenerative cell therapy.

DOXA Platform:A novel small-molecule CNS program aimed at addressing various central nervous system disorders.

Holistic Solutions:Comprehensive treatment approaches for various indications using advanced cell therapy technologies.

Specialties

Regenerative Cell Therapies Type 1 Diabetes Treatment Central Nervous System Disorders Human Pluripotent Stem Cell (hPSC) Technology Allogeneic Cell Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 1350000 MR: - FA: $1.35 million FAN: 1350000	D: 2026-04-01 FD: 2026-04-01	1 investors

Equity Financing Latest

2026-04-01

$1.4M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Julien Boisdron

Scientific Advisory Board, Chief Medical Officer, Roche

LinkedIn (Pro only)

T

Tamir Ben Hur

Professor of Neurology and Chairman, The Department of Neurology, Hadassah - Hebrew University Medical Center

J

Jeremy Shefner

Scientific Advisory Board, Chief Medical Officer, Barrow Neurological Institute

R

Ronen Twito

Executive Chairman & CEO

M

Michel Revel

Chief Scientific Officer

A

Alex Zwyer

Chief Business Officer & Executive Director

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

NewcelX Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised